• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液恶性肿瘤患者亲属对理想照护地点和死亡地点的看法:一项定性研究。

Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: A qualitative study.

机构信息

1 Epidemiology and Cancer Statistics Group, University of York, York, UK.

2 Department of Palliative Care, York Hospital, York, UK.

出版信息

Palliat Med. 2019 May;33(5):518-530. doi: 10.1177/0269216318824525. Epub 2019 Jan 30.

DOI:10.1177/0269216318824525
PMID:30696347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6507303/
Abstract

BACKGROUND

People with haematological malignancies have different end-of-life care patterns from those with other cancers and are more likely to die in hospital. Little is known about patient and relative preferences at this time and whether these are achieved.

AIM

To explore the experiences and reflections of bereaved relatives of patients with leukaemia, lymphoma or myeloma, and examine (1) preferred place of care and death; (2) perceptions of factors influencing attainment of preferences; and (3) changes that could promote achievement of preferences.

DESIGN

Qualitative interview study incorporating 'Framework' analysis.

SETTING/PARTICIPANTS: A total of 10 in-depth interviews with bereaved relatives.

RESULTS

Although most people expressed a preference for home death, not all attained this. The influencing factors include disease characteristics (potential for sudden deterioration and death), the occurrence and timing of discussions (treatment cessation, prognosis, place of care/death), family networks (willingness/ability of relatives to provide care, knowledge about services, confidence to advocate) and resource availability (clinical care, hospice beds/policies). Preferences were described as changing over time and some family members retrospectively came to consider hospital as the 'right' place for the patient to have died. Others shared strong preferences with patients for home death and acted to ensure this was achieved. No patients died in a hospice, and relatives identified barriers to death in this setting.

CONCLUSION

Preferences were not always achieved due to a series of complex, interrelated factors, some amenable to change and others less so. Death in hospital may be preferred and appropriate, or considered the best option in hindsight.

摘要

背景

与其他癌症患者相比,血液系统恶性肿瘤患者的临终关怀模式有所不同,他们更有可能在医院去世。目前,人们对患者和家属在这方面的偏好及其是否得到满足知之甚少。

目的

探讨白血病、淋巴瘤或骨髓瘤患者的家属在丧亲后的经历和反思,并探讨:(1)首选的关怀和死亡地点;(2)影响偏好实现的因素的看法;(3)可以促进偏好实现的变化。

设计

采用定性访谈研究,结合“框架”分析。

地点/参与者:共对 10 名丧亲的家属进行了深入访谈。

结果

尽管大多数人表示希望在家中去世,但并非所有人都能如愿。影响因素包括疾病特征(潜在的突然恶化和死亡)、讨论的发生和时间(停止治疗、预后、关怀地点/死亡)、家庭网络(亲属提供关怀的意愿/能力、对服务的了解、倡导的信心)和资源可用性(临床护理、临终关怀床位/政策)。偏好被描述为随着时间的推移而变化,一些家属后来认为医院是患者去世的“正确”地点。还有一些家属与患者有强烈的在家中去世的偏好,并采取行动确保这一愿望得以实现。没有患者在临终关怀机构去世,而家属认为在这种环境下死亡存在障碍。

结论

由于一系列复杂的、相互关联的因素,偏好并非总是能够实现,其中一些因素是可以改变的,而另一些因素则不然。在医院去世可能是首选和合适的,或者事后被认为是最佳选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/6507303/d85b089f9b99/10.1177_0269216318824525-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/6507303/d85b089f9b99/10.1177_0269216318824525-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/6507303/d85b089f9b99/10.1177_0269216318824525-fig1.jpg

相似文献

1
Perspectives of bereaved relatives of patients with haematological malignancies concerning preferred place of care and death: A qualitative study.血液恶性肿瘤患者亲属对理想照护地点和死亡地点的看法:一项定性研究。
Palliat Med. 2019 May;33(5):518-530. doi: 10.1177/0269216318824525. Epub 2019 Jan 30.
2
Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network.血液恶性肿瘤患者的首选和实际死亡地点:来自英国血液恶性肿瘤研究网络的报告。
BMJ Support Palliat Care. 2021 Mar;11(1):7-16. doi: 10.1136/bmjspcare-2019-002097. Epub 2020 May 11.
3
Patients with pancreatic cancer and relatives talk about preferred place of death and what influenced their preferences: a qualitative study.胰腺癌患者及其亲属谈论死亡的首选地点以及影响他们偏好的因素:一项定性研究。
BMJ Support Palliat Care. 2011 Dec;1(3):291-5. doi: 10.1136/bmjspcare-2011-000091. Epub 2011 Aug 25.
4
Determinants of hospital death in haematological cancers: findings from a qualitative study.血液系统癌症患者医院死亡的决定因素:一项定性研究的结果
BMJ Support Palliat Care. 2018 Mar;8(1):78-86. doi: 10.1136/bmjspcare-2016-001289. Epub 2017 Jun 29.
5
Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study.癌症患者临终关怀的质量和费用、偏好以及姑息治疗结局的差异,与死亡地点有关:QUALYCARE 研究。
BMC Cancer. 2010 Aug 2;10:400. doi: 10.1186/1471-2407-10-400.
6
Place of care and death preferences among recently bereaved family members: a cross-sectional survey.近期丧亲家庭成员的护理地点与死亡偏好:一项横断面调查。
BMJ Support Palliat Care. 2024 Dec 19;14(e3):e2904-e2913. doi: 10.1136/spcare-2023-004697.
7
End-of-life care and achieving preferences for place of death in England: results of a population-based survey using the VOICES-SF questionnaire.英国的临终关怀与实现死亡地点偏好:使用VOICES-SF问卷进行的基于人群调查结果
Palliat Med. 2014 May;28(5):412-21. doi: 10.1177/0269216313512012. Epub 2013 Nov 29.
8
Social and clinical determinants of preferences and their achievement at the end of life: prospective cohort study of older adults receiving palliative care in three countries.社会和临床决定因素对生命终末期偏好及其实现的影响:对三个国家接受姑息治疗的老年患者的前瞻性队列研究。
BMC Geriatr. 2017 Nov 23;17(1):271. doi: 10.1186/s12877-017-0648-4.
9
Which patients die in their preferred place? A secondary analysis of questionnaire data from bereaved relatives.哪些患者在他们偏好的地点去世?对失去亲人的亲属问卷调查数据的二次分析。
Palliat Med. 2018 Feb;32(2):347-356. doi: 10.1177/0269216317710383. Epub 2017 Jun 7.
10
Family Perspectives on Aggressive Cancer Care Near the End of Life.家庭对临终前积极癌症治疗的看法。
JAMA. 2016 Jan 19;315(3):284-92. doi: 10.1001/jama.2015.18604.

引用本文的文献

1
Challenges in hospice and end-of-life care in the transfusion-dependent patient.依赖输血患者的临终关怀与终末期护理面临的挑战。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):340-347. doi: 10.1182/hematology.2024000560.
2
Lived experiences of end-of-life care at home in the UK: a scoping review of qualitative research.英国居家临终关怀的生活体验:定性研究的范围综述。
Br J Gen Pract. 2024 Nov 28;74(749):e839-e844. doi: 10.3399/BJGP.2023.0349. Print 2024 Dec.
3
District nurses experiences in providing terminal care in rural and more urban districts. A qualitative study from the Faroe Islands.

本文引用的文献

1
Palliative care is effective: but hospital symptom outcomes superior.姑息治疗是有效的:但医院症状结局更优。
BMJ Support Palliat Care. 2020 Jun;10(2):186-190. doi: 10.1136/bmjspcare-2018-001534. Epub 2018 Aug 31.
2
Generalizability in Qualitative Research: A Tale of Two Traditions.定性研究的可推广性:两种传统的故事。
Qual Health Res. 2018 Nov;28(13):2094-2101. doi: 10.1177/1049732318788379. Epub 2018 Jul 25.
3
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.
农村和更城市化地区的地区护士在提供临终关怀方面的经验。法罗群岛的一项定性研究。
Scand J Prim Health Care. 2024 Sep;42(3):367-377. doi: 10.1080/02813432.2024.2329207. Epub 2024 Mar 14.
4
End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital.符合强化化疗条件的急性髓系白血病与侵袭性淋巴瘤患者的临终关怀:日本一家社区医院的观察性研究
Palliat Med Rep. 2023 Mar 17;4(1):71-78. doi: 10.1089/pmr.2022.0056. eCollection 2023.
5
Systematic Review and Meta-Synthesis about Patients with Hematological Malignancy and Palliative Care.血液恶性肿瘤患者的姑息治疗的系统评价和元综合
Asian Pac J Cancer Prev. 2022 Sep 1;23(9):2881-2890. doi: 10.31557/APJCP.2022.23.9.2881.
6
Factors influencing place of death and disenrollment among patients receiving specialist palliative care.影响接受专科姑息治疗患者死亡和退出医保地点的因素。
Acta Biomed. 2022 May 12;93(S2):e2022189. doi: 10.23750/abm.v93iS2.12637.
7
Exploring Experiences of Bereaved Caregivers of Older Adult Patients With Acute Myeloid Leukemia.探索老年急性髓系白血病患者丧亲照料者的体验。
Clin J Oncol Nurs. 2022 Apr 1;26(2):135-139. doi: 10.1188/22.CJON.135-139.
8
Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.队列简介更新:英国血液恶性肿瘤研究网络(HMRN)基于人群的队列。
Int J Epidemiol. 2022 Jun 13;51(3):e87-e94. doi: 10.1093/ije/dyab275.
9
What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?异体干细胞移植(allo-SCT)成人患者的姑息治疗知多少?
Ann Hematol. 2021 Jun;100(6):1377-1389. doi: 10.1007/s00277-021-04538-4. Epub 2021 May 6.
10
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?终末期血液恶性肿瘤患者生存照护中“善终”的目标:我们是否接近?
Curr Hematol Malig Rep. 2021 Apr;16(2):117-125. doi: 10.1007/s11899-021-00629-1. Epub 2021 Apr 16.
队列简介:血液恶性肿瘤研究网络(HMRN):一个基于英国人群的患者队列。
Int J Epidemiol. 2018 Jun 1;47(3):700-700g. doi: 10.1093/ije/dyy044.
4
Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.姑息治疗专家对转介血液科患者至其服务的看法:一项定性研究的结果。
BMC Palliat Care. 2018 Feb 21;17(1):33. doi: 10.1186/s12904-018-0289-1.
5
Palliative care in patients with haematological neoplasms: An integrative systematic review.血液病肿瘤患者的姑息治疗:综合系统评价。
Palliat Med. 2018 Jan;32(1):79-105. doi: 10.1177/0269216317735246. Epub 2017 Nov 13.
6
Advance Care Planning and Palliative Care Specialists in Malignant Hematology and Stem-Cell Transplantation: On Why It Takes A Village.恶性血液学和干细胞移植中的预先护理计划与姑息治疗专家:论为何需要众人协作。
J Oncol Pract. 2018 Jan;14(1):3-5. doi: 10.1200/JOP.2017.026930. Epub 2017 Oct 5.
7
Comparing the Palliative Care Needs of Patients With Hematologic and Solid Malignancies.比较血液系统恶性肿瘤和实体瘤患者的姑息治疗需求。
J Pain Symptom Manage. 2018 Jan;55(1):82-88.e1. doi: 10.1016/j.jpainsymman.2017.08.030. Epub 2017 Sep 5.
8
Honoring the voices of bereaved caregivers: a Metasummary of qualitative research.悼念护理者的声音:定性研究的综合分析。
BMC Palliat Care. 2017 Sep 6;16(1):48. doi: 10.1186/s12904-017-0231-y.
9
Is Early Palliative Care Feasible in Patients With Multiple Myeloma?多发性骨髓瘤患者实施早期姑息治疗是否可行?
J Pain Symptom Manage. 2017 Nov;54(5):692-700. doi: 10.1016/j.jpainsymman.2017.04.012. Epub 2017 Aug 12.
10
Determinants of hospital death in haematological cancers: findings from a qualitative study.血液系统癌症患者医院死亡的决定因素:一项定性研究的结果
BMJ Support Palliat Care. 2018 Mar;8(1):78-86. doi: 10.1136/bmjspcare-2016-001289. Epub 2017 Jun 29.